Rupinta, Edelyn Faye T.
HRN: 17-33-85 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5grams
PTOR
For Elective Repeat CS With BTL
Checking Final Appropriateness
11/18/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5 Gm
Q 8h
S/P Repeat LTCS W/ BTL
Checking Final Appropriateness